Gerresheimer AG Stock
€101.90
Your prediction
Gerresheimer AG Stock
Gerresheimer is a German-based company that specializes in the production of high-quality glass and plastic packaging solutions for the healthcare industry. The company's products are used to store and transport medicines, vaccinations, and other healthcare products. With a global footprint, Gerresheimer operates in Europe, North America, South America, and Asia, serving leading pharmaceutical and life science companies. The company is publicly traded on the Frankfurt Stock Exchange and has a strong reputation for innovation, quality, and sustainability.
Pros and Cons of Gerresheimer AG in the next few years
Pros
Cons
Performance of Gerresheimer AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gerresheimer AG | -0.590% | -1.631% | 5.834% | -0.195% | 8.237% | 20.305% | 49.308% |
| Neogen Corp. | 0.680% | 8.571% | 4.828% | - | - | - | - |
| Bio-Rad Labs Inc. A | 0.490% | 3.764% | 1.144% | -12.645% | 2.350% | -55.481% | -2.037% |
| Merit Medical Systems | -1.690% | -0.571% | 5.455% | 38.095% | 27.941% | 43.802% | 216.306% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Analyzing the financials of Gerresheimer, a notable player in the Healthcare Equipment & Supplies industry, reveals a company with a solid foundation yet facing some challenges that investors should take note of. The financial statements, including balance sheets, cash flow statements, and income statements, provide a comprehensive look into the company's operations, liquidity, and overall financial health. A review of various financial ratios further enhances understanding, depicting both strengths and areas needing attention.
Solid Revenue Growth: Gerresheimer showcased notable revenue figures, closing the last reported year at approximately €2.00 billion. This consistent revenue level suggests a solid market position, making it a player worthy of attention in the healthcare sector.
Operating Margin: The operating margin, currently at 11.08%, indicates that Gerresheimer maintains decent control over its direct costs relative to its revenue. This performance showcases an ability to manage expenses effectively while still generating profit.
Comments
News
EQS-News: Gerresheimer: EcoVadis Gold with further improved score
EQS-News: Gerresheimer remains on track in 1st half year 2024
EQS-News: Gerresheimer expands capacities for Medical Systems in the USA